Plain-English translation of NCT07235592 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing the PRESERFLO™ MicroShunt XI, a tiny surgically implanted tube designed to help lower pressure inside the eye for people with open-angle glaucoma. The device works by creating a small passageway that allows excess fluid (called aqueous humor) to drain from the front of the eye to a small pocket under the eye's outer layer, reducing eye pressure. Researchers are collecting safety and performance information on this device, which has already been approved for use in Europe.
Open-angle glaucoma can cause blindness if eye pressure isn't controlled, but some patients' pressure stays too high even when using the maximum tolerated eye drops. This trial exists to gather real-world safety and effectiveness data on this treatment option for people whose medications are no longer working well enough.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would receive outpatient surgery to have the MicroShunt XI implanted in your eye by a glaucoma specialist. The study will follow your eye pressure and overall eye health after the surgery through regular check-up visits. Researchers will monitor you to ensure the device is working safely and effectively at lowering your eye pressure over time.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Austria
Belgium
Germany
Italy